Search results for " integrated"

showing 10 items of 307 documents

A high resolution TDC subsystem

1994

A high resolution TDC subsystem was developed at the Institute for Nuclear Physics in Mainz. The TDC chip offers a time resolution of less than 300 ps and a programmable measurement range from O to 16 /spl mu/sec. The time measurement is done with a new, purely digital counting method. The chip can be operated in common start or common stop mode. In common start mode the chip is able to store up to 4 multiple hits per channel. The chip is used to build a transputer controlled subsystem for the measurement of the drift times of a vertical drift chamber. The design of the subsystem will be described and the first results from the tests of the prototype system will be presented. >

Nuclear and High Energy PhysicsEngineeringbusiness.industryTransputerInstrumentationElectrical engineeringChipParticle detectorNuclear Energy and EngineeringApplication-specific integrated circuitCMOSElectrical and Electronic EngineeringbusinessElectronic circuitCommunication channelIEEE Transactions on Nuclear Science
researchProduct

Performance of the front-end electronics of the ANTARES neutrino telescope

2010

ANTARES is a high-energy neutrino telescope installed in the Mediterranean Sea at a depth of 2475 m. It consists of a three-dimensional array of optical modules, each containing a large photomultiplier tube. A total of 2700 front-end ASICs named Analogue Ring Samplers (ARS) process the phototube signals, measure their arrival time, amplitude and shape as well as perform monitoring and calibration tasks. The ARS chip processes the analogue signals from the optical modules and converts information into digital data. All the information is transmitted to shore through further multiplexing electronics and an optical link. This paper describes the performance of the ARS chip; results from the fu…

Nuclear and High Energy PhysicsPhotomultiplier[PHYS.ASTR.IM]Physics [physics]/Astrophysics [astro-ph]/Instrumentation and Methods for Astrophysic [astro-ph.IM]Physics::Instrumentation and DetectorsOptical linkDigital dataFOS: Physical sciencesAnalog-to-digital converterNeutrino telescope01 natural sciencesMultiplexinglaw.inventionPhototubeApplication-specific integrated circuitPhotomultiplier tubelawASICs0103 physical sciences14. Life underwater010306 general physicsInstrumentation and Methods for Astrophysics (astro-ph.IM)InstrumentationPhysics010308 nuclear & particles physicsbusiness.industryASICAstrophysics::Instrumentation and Methods for AstrophysicsElectrical engineeringCIRCUITFront-end electronicsChip[SDU.ASTR.IM]Sciences of the Universe [physics]/Astrophysics [astro-ph]/Instrumentation and Methods for Astrophysic [astro-ph.IM]Física nuclearUNDERWATER DETECTORasic; front-end electronics; neutrino telescope; photomultiplier tubeAstrophysics - Instrumentation and Methods for AstrophysicsbusinessSYSTEMNuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
researchProduct

Detector characterization and first coincidence tests of a Compton telescope based on LaBr3 crystals and SiPMs

2011

International audience; A Compton telescope for dose monitoring in hadron therapy consisting of several layers of continuous LaBr3 crystals coupled to silicon photomultiplier (SiPM) arrays is under development within the ENVISION project. In order to test the possibility of employing such detectors for the telescope, a detector head consisting of a continuous 16 mm×18 mm×5 mm LaBr3 crystal coupled to a SiPM array has been assembled and characterized, employing the SPIROC1 ASIC as readout electronics. The best energy resolution obtained at 511 keV is 6.5% FWHM and the timing resolution is 3.1 ns FWHM. A position determination method for continuous crystals is being tested, with promising res…

Nuclear and High Energy PhysicsPhysics::Instrumentation and DetectorsCompton telescopeSiPM01 natural sciences7. Clean energyCoincidence030218 nuclear medicine & medical imaginglaw.inventionTelescope03 medical and health sciencesHadron therapy0302 clinical medicineOpticsSilicon photomultiplierApplication-specific integrated circuitlaw0103 physical sciencesCompton imaging[PHYS.PHYS.PHYS-INS-DET]Physics [physics]/Physics [physics]/Instrumentation and Detectors [physics.ins-det][SPI.NANO]Engineering Sciences [physics]/Micro and nanotechnologies/MicroelectronicsInstrumentationPhysicsContinuous crystal010308 nuclear & particles physicsbusiness.industryResolution (electron density)DetectorMPPCG-APDLaBr3Full width at half maximumbusiness
researchProduct

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, mu…

2013

Contains fulltext : 118365.pdf (Publisher’s version ) (Closed access) BACKGROUND: Until now, only imatinib and sunitinib have proven clinical benefit in patients with gastrointestinal stromal tumours (GIST), but almost all metastatic GIST eventually develop resistance to these agents, resulting in fatal disease progression. We aimed to assess efficacy and safety of regorafenib in patients with metastatic or unresectable GIST progressing after failure of at least imatinib and sunitinib. METHODS: We did this phase 3 trial at 57 hospitals in 17 countries. Patients with histologically confirmed, metastatic or unresectable GIST, with failure of at least previous imatinib and sunitinib were rando…

OncologyMaleIndolesPyridinesSettore MED/06 - Oncologia MedicaSU11248MedizinPiperazineslaw.inventionchemistry.chemical_compoundRandomized controlled triallawClinical endpointSunitinibTreatment Failureregorafenib; gastrointestinal stromal tumours; imatinib and sunitinibGastrointestinal Neoplasmseducation.field_of_studyGiSTSunitinibKITAge-related aspects of cancer Quality of hospital and integrated care [ONCOL 2]General MedicineMiddle AgedSurvival RateBenzamidesImatinib MesylateFemaleADJUVANT IMATINIBTYROSINE KINASE INHIBITORColorectal NeoplasmsLife Sciences & Biomedicinemedicine.drugGROWTH-FACTORmedicine.medical_specialtyGastrointestinal Stromal TumorsPopulationMESYLATEAntineoplastic AgentsIMATINIBArticleMECHANISMSMedicine General & InternalDouble-Blind MethodTranslational research [ONCOL 3]General & Internal MedicineRegorafenibInternal medicineMANAGEMENTmedicineHumansPyrroleseducationProtein Kinase InhibitorsAgedScience & TechnologyGASTROINTESTINAL STROMAL TUMOURSimatinib and sunitinibMUTATIONSbusiness.industryPhenylurea CompoundsGIST regorafenib imatinib sunitinib phase III trialSurgeryClinical trialImatinib mesylatePyrimidineschemistryregorafenibbusinessRESISTANCE
researchProduct

Integration of oncology and palliative care: a Lancet Oncology Commission.

2018

© 2018 Elsevier Ltd Full integration of oncology and palliative care relies on the specific knowledge and skills of two modes of care: the tumour-directed approach, the main focus of which is on treating the disease; and the host-directed approach, which focuses on the patient with the disease. This Commission addresses how to combine these two paradigms to achieve the best outcome of patient care. Randomised clinical trials on integration of oncology and palliative care point to health gains: improved survival and symptom control, less anxiety and depression, reduced use of futile chemotherapy at the end of life, improved family satisfaction and quality of life, and improved use of health-…

Oncologymedicine.medical_specialtyHealth Knowledge Attitudes PracticePalliative careAttitude to DeathAttitude of Health PersonnelMEDLINEMedical Oncology03 medical and health sciences0302 clinical medicineQuality of life (healthcare)nursingMultidisciplinary approachInternal medicineNeoplasmsHealth caremedicinecancerHumans030212 general & internal medicineOncology & CarcinogenesisCooperative BehaviorPatient Care Teambusiness.industryDelivery of Health Care IntegratedPalliative CareMental health3. Good healthIntegrated careClinical trialTreatment OutcomeOncology030220 oncology & carcinogenesisCritical PathwaysQuality of LifeInterdisciplinary CommunicationbusinessThe Lancet. Oncology
researchProduct

Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary to…

2015

To investigate the feasibility and tolerance in the use of adjuvant intensity modulated radiation therapy (IMRT) and simultaneous integrated boost in patients with a diagnosis of breast cancer after breast-conserving surgery.Between September 2011 to February 2013, 112 women with a diagnosis of early breast cancer (T1-2, N0-1, M0) were treated with IMRT and simultaneous integrated boost after breast-conserving surgery in our institution. A dose of 50Gy in 25 fractions was prescribed to the whole breast and an additional dose of radiation was prescribed on the tumour bed. A dose prescription of 60Gy in 25 fractions to the tumour bed was used in patients with negative margins after surgery, w…

Oncologymedicine.medical_treatmentSegmentalMastectomy SegmentalSeverity of Illness IndexBreast cancerNuclear Medicine and ImagingDuctalIntensity-Modulated80 and overBreastMastectomyAdjuvantEarly breast cancerAged 80 and overCarcinoma Ductal BreastSIBRadiotherapy DosageMiddle AgedOncologyBreast cancer; IMRT; SIB; Toxicity; Adult; Aged; Aged 80 and over; Breast Neoplasms; Carcinoma Ductal Breast; Carcinoma Lobular; Esthetics; Feasibility Studies; Female; Follow-Up Studies; Humans; Mastectomy Segmental; Middle Aged; Radiodermatitis; Radiotherapy Dosage; Radiotherapy Adjuvant; Severity of Illness Index; Radiotherapy Intensity-Modulated; Oncology; Radiology Nuclear Medicine and ImagingToxicityFemaleRadiologyRadiodermatitisRadiologyAdjuvantSimultaneous integrated boostAdultmedicine.medical_specialtyEstheticsBreast NeoplasmsLobularBreast cancerInternal medicineSeverity of illnessmedicineHumansRadiology Nuclear Medicine and imagingIMRTAgedToxicityRadiotherapybusiness.industryCarcinomaIntensity-modulated radiation therapymedicine.diseaseAcute toxicityBreast cancer; IMRT; SIB; Toxicity; Oncology; Radiology Nuclear Medicine and ImagingCarcinoma LobularFeasibility StudiesRadiotherapy AdjuvantRadiotherapy Intensity-ModulatedbusinessFollow-Up Studies
researchProduct

Halide perovskite amplifiers integrated in polymer waveguides

2016

Semiconductor organometallic halide perovskites (CH 3 NH 3 PbX 3 , X=Cl, Br, I) (HPVK) have emerged as a new promising material able to improve the optoelectronic technology performance. Although this material has mostly been applied to improve the efficiency of photovoltaic devices, it also shows amazing properties for photonic applications. In particular, HPVK exhibits high photoluminescence (PL) quantum yield (up to 70%) at room temperature together with a tunable band-gap controlled by its chemical composition. In addition, since HPVKs is deposited in solution at room conditions, it can be easily incorporated in different photonic structures to efficiently exploit its emission propertie…

Optical amplifierSilicon photonicsMaterials sciencebusiness.industryPhotonic integrated circuit02 engineering and technology010402 general chemistry021001 nanoscience & nanotechnology01 natural sciencesWaveguide (optics)0104 chemical sciencesOptoelectronicsSemiconductor optical gainSpontaneous emissionStimulated emissionPhotonics0210 nano-technologybusiness2016 18th International Conference on Transparent Optical Networks (ICTON)
researchProduct

Soft proton exchanged channel waveguides in congruent lithium tantalate for frequency doubling

2010

We report on stable optical waveguides fabricated by soft-proton exchange in periodically-poled congruent lithium tantalate in the a-phase. The channel waveguides are characterized in the telecom wavelength range in terms of both linear properties and frequency doubling. The measurements yield a nonlinear coefficient of about 9.5pm/V, demonstrating that the nonlinear optical properties of lithium tantalate are left nearly unaltered by the process. (C) 2010 Optical Society of America

Optical frequency multiplierMaterials scienceProtonPhysics::OpticsTantalumLithiumNonlinear opticalchemistry.chemical_compoundOpticsbusiness.industrySecond-harmonic generationOxidesEquipment DesignSurface Plasmon ResonanceAtomic and Molecular Physics and OpticsEquipment Failure AnalysisNonlinear systemRefractometrychemistryNonlinear DynamicsYield (chemistry)Lithium tantalateComputer-Aided DesignChannel (broadcasting)ProtonsbusinessNonlinear optics Integrated optics materials Waveguides Nonlinear optical devices
researchProduct

Kinetic Monte Carlo modeling of Y2O3 nano-cluster formation in radiation resistant matrices

2018

This work has been carried out within the framework of the EUROfusion Consortium and has received funding from the Euratom research and training programme 2014-2018 under grant agreement No 633053. The views and opinions expressed herein do not necessarily reflect those of the European Commission.

Ostwald ripeningNuclear and High Energy PhysicsScale (ratio)02 engineering and technology01 natural sciences7. Clean energysymbols.namesake0103 physical sciencesCluster (physics):NATURAL SCIENCES:Physics [Research Subject Categories]Kinetic Monte CarloAutoregressive integrated moving averageLimit (mathematics)InstrumentationOxide dispersion strengthened (ODS) steels010302 applied physicsPhysicsY2O3 nano-clustersOstwald ripeningRadiusKinetic Monte Carlo021001 nanoscience & nanotechnologyComputational physicsCoarseningsymbolsParticle0210 nano-technologyNuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
researchProduct

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and …

2016

WOS: 000393031600001

PREDICTIONInternational CooperationPoolingInformation Storage and RetrievalDisease030204 cardiovascular system & hematologyGUIDELINESDoenças Cardio e Cérebro-vascularesLDL-Cholesterol0302 clinical medicineCardiovascular DiseaseMedicineData MiningCardiac and Cardiovascular Systems030212 general & internal medicineRegistriesDisease management (health)Cooperative BehaviorGENERAL-POPULATIONRISKFamilial hypercholesterolaemia ; LDL-Cholesterol ; Cardiovascular disease ; RegistryKardiologiCONSENSUS PANELDelivery of Health Care IntegratedGeneral MedicineOrvostudományokCardiovascular diseasePREVALENCE3. Good healthTreatment OutcomeCARDIOVASCULAR-DISEASEResearch DesignFamilial hypercholesterolaemiaCardiology and Cardiovascular MedicineRegistrymedicine.medical_specialtyBest practiceKlinikai orvostudományokAccess to InformationHyperlipoproteinemia Type II03 medical and health sciencesEUROPEAN ATHEROSCLEROSIS SOCIETYInternal MedicineHumansOrganizational ObjectivesBespokeStudy DesignGUIDANCEbusiness.industryPublic healthStudy designProfessional Practice GapsData sharingClinical trialCardiovascular System & Hematology3121 General medicine internal medicine and other clinical medicineFamily medicineFamilial hypercholesterolaemia; LDL-Cholesterol; Cardiovascular disease; Registry; Study design; Familial Hypercholesterolaemia Studies CollaborationFamilial Hypercholesterolaemia Studies CollaborationFamilial HypercholesterolaemiaINDIVIDUAL PARTICIPANT DATAbusiness
researchProduct